ProfileGDS5822 / ILMN_2540058
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 7% 17% 1% 13% 5% 11% 19% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 197
GSM1276600PDAC Late Ablation Control 214.117
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 13.51
GSM1276603PDAC Late Ablation 29.713
GSM1276604PDAC Late Ablation 35.65
GSM1303940PDAC Late Ablation_anti-CTLA4 19.911
GSM1303941PDAC Late Ablation_anti-CTLA4 210.419
GSM1303942PDAC Late Ablation_anti-CTLA4 3